Sarah Spiegel Net Worth

Sarah Spiegel is an actress and singer who has had guest star roles on national television shows such as Samantha Who?, The King of Queens, Boston Public, NCIS: Naval Criminal Investigative Service, Living with Fran, and Providence. She has also performed in stage and theatrical productions such as Joseph and the Amazing Technicolor Dreamcoat, Dancing at Lughnasa, The Caucasian Chalk Circle, and The Threepenny Opera. Sarah has toured with Louis Prima Jr. and the Witnesses and is known as "The Regal Miss Sarah Spiegel" in Southern Florida. She has written a one woman show, "Through the Perilous Fight (We Never Stopped Singing)", which pays tribute to the music of World War II. Sarah has also been a national spokesperson for General Motors Corporation and has released her version of "I Dreamed a Dream" on Jesse Saunders' BrokenRecords label. She is currently recording her first full length, contemporary/pop CD with platinum selling artist, Eddie Hedges producing.
Sarah Spiegel is a member of Actress

Age, Biography and Wiki

Who is it?	Actress
Education	BSc., Hebrew University of Jerusalem PhD., Weizmann Institute of Science
Known for	Discovery of sphingosine-1-phosphate molecule
Fields	Cell biology, biochemistry
Institutions	Virginia Commonwealth University VCU Massey Cancer Center

💰 Net worth

Sarah Spiegel is an incredibly talented actress and singer whose net worth is projected to range from $100,000 to $1 million in 2024. With an impressive portfolio, she has captivated audiences with her guest star appearances on popular national television shows including Samantha Who?, The King of Queens, Boston Public, NCIS: Naval Criminal Investigative Service, Living with Fran, and Providence. Sarah's undeniable talent and charm have earned her a commendable reputation in the industry, and her net worth reflects her well-deserved success.

Some Sarah Spiegel images

Biography/Timeline

1974

Sarah Spiegel received her bachelor of science degree in chemistry and biochemistry at the Hebrew University of Jerusalem in 1974. She did graduate work in biochemistry under Professor Meir Wilchek at the Weizmann Institute of Science in Rehovot, Israel, where she earned her PhD in biochemistry in 1983, before relocating to the United States.

1984

Spiegel did a postdoctoral fellowship at the Membrane Biochemistry Section at the National Institute of Neurological Disorders and Stroke at the National Institutes of Health in Bethesda, Maryland, from 1984 to 1986. She then moved to Georgetown University School of Medicine to serve as Assistant Professor in the Department of Biochemistry and Molecular Biology from 1987 to 1992, and Associate Professor and Director of the Graduate Program in Biochemistry and Molecular Biology from 1992 to 1996. This was followed by a full professorship in Biochemistry and Molecular Biology at the University Medical School from 1996 to 2001.

1990

Spiegel is credited with the discovery of the sphingosine-1-phosphate (S1P) molecule in the mid-1990s. This molecule has been identified as a signaler in the spread of cancer, inflammation, and cardiovascular disease. In 2013 Spiegel and Santiago Lima, PhD, reported in the journal Structure on their discovery of the atomic structure of the enzyme sphingosine kinase 1, which produces the S1P molecule.

2000

Since 2000, she has served on the editorial boards of the Journal of Biological Chemistry, Glycoconjugate Journal, Biochimica et Biophysica Acta, and Signal Transduction.

2002

Spiegel became Professor and Chair of the Department of Biochemistry at Virginia Commonwealth University in 2002, a position she holds to this day. Since 2005, she has also served as Director of the Cancer Cell Biology Program at the VCU Massey Cancer Center.

2003

Spiegel's research has been continually funded for a period of nearly 20 years by grants from the National Institutes of Health. In 2003 she was awarded the National Institutes of Health MERIT Award of nearly $2.1 million for further research on S1P.